TONIX PHARMACEUTICALS HOLDING CORP. Research and Development Expense
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Research and Development Expense of $19.42 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for the quarter ending 2026-06-30 was $19.42M, a 79.45% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for the quarter ending 2026-03-31 was $18.21M, a 144.93% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for the quarter ending 2025-12-31 was $16.94M, a 104.18% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for the quarter ending 2025-09-30 was $9.29M, a 1.92% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for fiscal 2025 was $44.49M, a 11.29% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for fiscal 2024 was $39.97M, a 53.87% decline from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for fiscal 2023 was $86.66M, a 5.84% increase from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. research and development expense for fiscal 2022 was $81.88M, a 18.94% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 55 month | Research and Development Expense 58 month | Research and Development Expense 61 month | Research and Development Expense 64 month | Research and Development Expense 67 month | Research and Development Expense 70 month | Research and Development Expense 73 month | Research and Development Expense 76 month | Research and Development Expense 79 month | Research and Development Expense 82 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.42M 10-Q · filed 2026-08-10 | $37.63M 10-Q · filed 2026-08-10 | $54.57M derived: sum of 3 quarters · filed 2026-08-10 | $63.86M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2026-03-31 | $18.21M 10-Q · filed 2026-05-11 | $35.15M derived: sum of 2 quarters · filed 2026-05-11 | $44.44M derived: sum of 3 quarters · filed 2026-05-11 | $55.26M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-12-31 | $16.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $26.23M derived: sum of 2 quarters · filed 2026-03-12 | $37.05M derived: sum of 3 quarters · filed 2026-08-10 | $44.49M 10-K · filed 2026-03-12 | ||||||||||||||
| 2025-09-30 | $9.29M 10-Q · filed 2025-11-10 | $20.11M derived: sum of 2 quarters · filed 2026-08-10 | $27.55M 10-Q · filed 2025-11-10 | $35.84M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-06-30 | $10.82M 10-Q · filed 2026-08-10 | $18.26M 10-Q · filed 2026-08-10 | $26.55M derived: sum of 3 quarters · filed 2026-08-10 | $35.67M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-03-31 | $7.44M 10-Q · filed 2026-05-11 | $15.73M derived: sum of 2 quarters · filed 2026-05-11 | $24.85M derived: sum of 3 quarters · filed 2026-05-11 | $34.55M derived: sum of 4 quarters · filed 2026-05-11 | ||||||||||||||
| 2024-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $17.41M derived: sum of 2 quarters · filed 2026-03-12 | $27.11M derived: sum of 3 quarters · filed 2026-03-12 | $39.97M 10-K · filed 2026-03-12 | ||||||||||||||
| 2024-09-30 | $9.11M 10-Q · filed 2025-11-10 | $18.81M derived: sum of 2 quarters · filed 2025-11-10 | $31.68M 10-Q · filed 2025-11-10 | $48.80M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||
| 2024-06-30 | $9.70M 10-Q · filed 2025-08-11 | $22.56M 10-Q · filed 2025-08-11 | $39.68M derived: sum of 3 quarters · filed 2025-08-11 | $60.73M derived: sum of 4 quarters · filed 2025-08-11 | ||||||||||||||
| 2024-03-31 | $12.86M 10-Q · filed 2025-05-12 | $29.98M derived: sum of 2 quarters · filed 2025-05-12 | $51.03M derived: sum of 3 quarters · filed 2025-05-12 | $73.01M derived: sum of 4 quarters · filed 2025-05-12 | ||||||||||||||
| 2023-12-31 | $17.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $38.17M derived: sum of 2 quarters · filed 2025-03-18 | $60.15M derived: sum of 3 quarters · filed 2025-03-18 | $86.66M 10-K · filed 2025-03-18 | ||||||||||||||
| 2023-09-30 | $21.05M 10-Q · filed 2024-11-12 | $43.03M derived: sum of 2 quarters · filed 2024-11-12 | $69.53M 10-Q · filed 2024-11-12 | $94.21M derived: sum of 4 quarters · filed 2024-11-12 | ||||||||||||||
| 2023-06-30 | $21.98M 10-Q · filed 2024-08-16 | $48.49M 10-Q · filed 2024-08-16 | $73.16M derived: sum of 3 quarters · filed 2024-08-16 | $95.36M derived: sum of 4 quarters · filed 2024-08-16 | ||||||||||||||
| 2023-03-31 | $26.51M 10-Q · filed 2024-05-13 | $51.19M derived: sum of 2 quarters · filed 2024-05-13 | $73.39M derived: sum of 3 quarters · filed 2024-05-13 | $89.97M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||||
| 2022-12-31 | $24.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $46.88M derived: sum of 2 quarters · filed 2024-04-01 | $63.45M derived: sum of 3 quarters · filed 2024-04-01 | $81.88M 10-K · filed 2024-04-01 | ||||||||||||||
| 2022-09-30 | $22.20M 10-Q · filed 2023-11-09 | $38.78M derived: sum of 2 quarters · filed 2023-11-09 | $57.20M 10-Q · filed 2023-11-09 | $79.50M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | $16.58M 10-Q · filed 2023-08-10 | $35.00M 10-Q · filed 2023-08-10 | $57.30M derived: sum of 3 quarters · filed 2023-08-10 | $70.38M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||||||
| 2022-03-31 | $18.42M 10-Q · filed 2023-05-08 | $40.72M derived: sum of 2 quarters · filed 2023-05-08 | $53.80M derived: sum of 3 quarters · filed 2023-05-08 | $71.93M derived: sum of 4 quarters · filed 2023-05-08 | ||||||||||||||
| 2021-12-31 | $22.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $35.38M derived: sum of 2 quarters · filed 2023-03-13 | $53.51M derived: sum of 3 quarters · filed 2023-03-13 | $68.84M 10-K · filed 2023-03-13 | ||||||||||||||
| 2021-09-30 | $13.08M 10-Q · filed 2022-11-07 | $31.21M derived: sum of 2 quarters · filed 2022-11-07 | $46.54M 10-Q · filed 2022-11-07 | $58.64M derived: sum of 4 quarters · filed 2022-11-07 | ||||||||||||||
| 2021-06-30 | $18.13M 10-Q · filed 2022-08-08 | $33.46M 10-Q · filed 2022-08-08 | $45.56M derived: sum of 3 quarters · filed 2022-08-08 | $54.37M derived: sum of 4 quarters · filed 2022-08-08 | ||||||||||||||
| 2021-03-31 | $15.33M 10-Q · filed 2022-05-09 | $27.42M derived: sum of 2 quarters · filed 2022-05-09 | $36.24M derived: sum of 3 quarters · filed 2022-05-09 | $46.81M derived: sum of 4 quarters · filed 2022-05-09 | ||||||||||||||
| 2020-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $20.91M derived: sum of 2 quarters · filed 2022-03-14 | $31.48M derived: sum of 3 quarters · filed 2022-03-14 | $36.16M 10-K · filed 2022-03-14 | ||||||||||||||
| 2020-09-30 | $8.81M 10-Q · filed 2021-11-08 | $19.38M derived: sum of 2 quarters · filed 2021-11-08 | $24.06M 10-Q · filed 2021-11-08 | $29.75M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||||
| 2020-06-30 | $10.57M 10-Q · filed 2021-08-09 | $15.25M 10-Q · filed 2021-08-09 | $20.94M derived: sum of 3 quarters · filed 2021-08-09 | $25.99M derived: sum of 4 quarters · filed 2021-08-09 | ||||||||||||||
| 2020-03-31 | $4.68M 10-Q · filed 2021-05-10 | $10.37M derived: sum of 2 quarters · filed 2021-05-10 | $15.42M derived: sum of 3 quarters · filed 2021-05-10 | $18.97M derived: sum of 4 quarters · filed 2021-05-10 | ||||||||||||||
| 2019-12-31 | $5.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $10.74M derived: sum of 2 quarters · filed 2021-03-15 | $14.30M derived: sum of 3 quarters · filed 2021-03-15 | $18.19M 10-K · filed 2021-03-15 | ||||||||||||||
| 2019-09-30 | $5.05M 10-Q · filed 2020-11-09 | $8.61M derived: sum of 2 quarters · filed 2020-11-09 | $12.50M 10-Q · filed 2020-11-09 | $17.56M derived: sum of 4 quarters · filed 2020-11-09 | ||||||||||||||
| 2019-06-30 | $3.55M 10-Q · filed 2020-08-10 | $7.45M 10-Q · filed 2020-08-10 | $12.51M derived: sum of 3 quarters · filed 2020-08-10 | $15.77M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||
| 2019-03-31 | $3.90M 10-Q · filed 2020-05-12 | $8.95M derived: sum of 2 quarters · filed 2020-05-12 | $12.22M derived: sum of 3 quarters · filed 2020-05-12 | $16.28M derived: sum of 4 quarters · filed 2020-05-12 | ||||||||||||||
| 2018-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $8.32M derived: sum of 2 quarters · filed 2020-03-24 | $12.39M derived: sum of 3 quarters · filed 2020-03-24 | $17.56M 10-K · filed 2020-03-24 | ||||||||||||||
| 2018-09-30 | $3.26M 10-Q · filed 2019-11-08 | $7.33M derived: sum of 2 quarters · filed 2019-11-08 | $12.50M 10-Q · filed 2019-11-08 | $16.14M derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||
| 2018-06-30 | $4.07M 10-Q · filed 2019-08-12 | $9.24M 10-Q · filed 2019-08-12 | $12.87M derived: sum of 3 quarters · filed 2019-08-12 | $16.78M derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||
| 2018-03-31 | $5.17M 10-Q · filed 2019-05-13 | $8.80M derived: sum of 2 quarters · filed 2019-05-13 | $12.71M derived: sum of 3 quarters · filed 2019-05-13 | $15.52M derived: sum of 4 quarters · filed 2019-05-13 | ||||||||||||||
| 2017-12-31 | $3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $7.54M derived: sum of 2 quarters · filed 2019-03-18 | $10.35M derived: sum of 3 quarters · filed 2019-03-18 | $13.34M 10-K · filed 2019-03-18 | ||||||||||||||
| 2017-09-30 | $3.91M 10-Q · filed 2018-11-09 | $6.71M derived: sum of 2 quarters · filed 2018-11-09 | $9.71M 10-Q · filed 2018-11-09 | $14.59M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||||||
| 2017-06-30 | $2.81M 10-Q · filed 2018-08-13 | $5.80M 10-Q · filed 2018-08-13 | $10.68M derived: sum of 3 quarters · filed 2018-08-13 | $16.15M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | $2.99M 10-Q · filed 2018-05-11 | $7.87M derived: sum of 2 quarters · filed 2018-05-11 | $13.34M derived: sum of 3 quarters · filed 2018-05-11 | $20.86M derived: sum of 4 quarters · filed 2018-05-11 | ||||||||||||||
| 2016-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $10.35M derived: sum of 2 quarters · filed 2018-03-09 | $17.86M derived: sum of 3 quarters · filed 2018-03-09 | $28.53M 10-K · filed 2018-03-09 | ||||||||||||||
| 2016-09-30 | $5.47M 10-Q · filed 2017-11-06 | $12.98M derived: sum of 2 quarters · filed 2017-11-06 | $23.65M 10-Q · filed 2017-11-06 | $33.14M derived: sum of 4 quarters · filed 2017-11-06 | ||||||||||||||
| 2016-06-30 | $7.52M 10-Q · filed 2017-08-11 | $18.19M 10-Q · filed 2017-08-11 | $27.68M derived: sum of 3 quarters · filed 2017-08-11 | $37.99M derived: sum of 4 quarters · filed 2017-08-11 | ||||||||||||||
| 2016-03-31 | $10.67M 10-Q · filed 2017-05-12 | $20.16M derived: sum of 2 quarters · filed 2017-05-12 | $30.48M derived: sum of 3 quarters · filed 2017-05-12 | $39.35M derived: sum of 4 quarters · filed 2017-05-12 | ||||||||||||||
| 2015-12-31 | $9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $19.80M derived: sum of 2 quarters · filed 2017-04-13 | $28.68M derived: sum of 3 quarters · filed 2017-04-13 | $35.50M 10-K · filed 2017-04-13 | ||||||||||||||
| 2015-09-30 | $10.31M 10-Q · filed 2016-11-10 | $19.18M derived: sum of 2 quarters · filed 2016-11-10 | $26.01M 10-Q · filed 2016-11-10 | $31.79M derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||||||
| 2015-06-30 | $8.87M 10-Q · filed 2016-08-05 | $15.70M 10-Q · filed 2016-08-05 | $21.48M derived: sum of 3 quarters · filed 2016-08-05 | $26.69M derived: sum of 4 quarters · filed 2016-08-05 | ||||||||||||||
| 2015-03-31 | $6.83M 10-Q · filed 2016-05-06 | $12.60M derived: sum of 2 quarters · filed 2016-05-06 | $17.82M derived: sum of 3 quarters · filed 2016-05-06 | $21.90M derived: sum of 4 quarters · filed 2016-05-06 | ||||||||||||||
| 2014-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $10.99M derived: sum of 2 quarters · filed 2016-03-03 | $15.07M derived: sum of 3 quarters · filed 2016-03-03 | $18.62M 10-K · filed 2016-03-03 | ||||||||||||||
| 2014-09-30 | $5.22M 10-Q · filed 2015-11-06 | $9.29M derived: sum of 2 quarters · filed 2015-11-06 | $12.84M 10-Q · filed 2015-11-06 | $14.17M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||||
| 2014-06-30 | $4.08M 10-Q · filed 2015-08-07 | $7.63M 10-Q · filed 2015-08-07 | $8.95M derived: sum of 3 quarters · filed 2016-03-03 | $10.59M derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||||
| 2014-03-31 | $3.55M 10-Q · filed 2015-05-08 | $4.88M derived: sum of 2 quarters · filed 2016-03-03 | $6.51M derived: sum of 3 quarters · filed 2016-03-03 | $7.46M derived: sum of 4 quarters · filed 2016-03-03 | $12.73M 10-Q · filed 2014-05-13 | |||||||||||||
| 2013-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $2.96M derived: sum of 2 quarters · filed 2016-03-03 | $3.91M derived: sum of 3 quarters · filed 2016-03-03 | $4.65M 10-K · filed 2016-03-03 | $9.19M 10-K · filed 2014-03-28 | |||||||||||||
| 2013-09-30 | $1.64M 10-Q · filed 2014-11-07 | $2.58M derived: sum of 2 quarters · filed 2014-11-07 | $3.32M 10-Q · filed 2014-11-07 | $3.32M 10-Q · filed 2013-11-13 | $4.02M derived: sum of 4 quarters · filed 2014-11-07 | $7.86M 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | $944.00K 10-Q · filed 2014-08-08 | $944.00K 10-Q · filed 2013-08-14 | $1.69M 10-Q · filed 2014-08-08 | $1.68M 10-Q · filed 2013-08-14 | $2.39M derived: sum of 3 quarters · filed 2014-08-08 | $3.04M derived: sum of 4 quarters · filed 2014-08-08 | $6.22M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $741.00K 10-Q · filed 2014-05-13 | $740.63K 10-Q · filed 2013-05-07 | $1.44M derived: sum of 2 quarters · filed 2014-05-13 | $2.10M derived: sum of 3 quarters · filed 2014-05-13 | $2.76M derived: sum of 4 quarters · filed 2014-05-13 | $5.28M 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | $700.44K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $1.36M derived: sum of 2 quarters · filed 2014-03-28 | $2.02M derived: sum of 3 quarters · filed 2014-03-28 | $2.58M 10-K · filed 2014-03-28 | $2.58M 10-K · filed 2013-03-11 | $4.54M 10-K/A · filed 2013-11-22 | ||||||||||||
| 2012-09-30 | $658.14K 10-Q · filed 2012-11-14 | $1.32M derived: sum of 2 quarters · filed 2013-11-13 | $1.88M 10-Q · filed 2013-11-13 | $2.24M derived: sum of 4 quarters · filed 2013-11-22 | $3.84M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $658.14K 10-Q · filed 2013-11-13 | $827.79K 10-Q · filed 2012-08-13 | $1.23M 10-Q · filed 2013-08-14 | $1.58M derived: sum of 3 quarters · filed 2013-11-22 | $2.07M derived: sum of 4 quarters · filed 2013-11-22 | $3.18M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | $397.63K 10-Q · filed 2013-05-07 | $921.30K derived: sum of 2 quarters · filed 2013-11-22 | $1.41M derived: sum of 3 quarters · filed 2013-11-22 | $1.48M derived: sum of 4 quarters · filed 2013-11-22 | $2.35M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $523.67K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $1.02M derived: sum of 2 quarters · filed 2013-11-22 | $1.08M derived: sum of 3 quarters · filed 2013-11-22 | $1.16M 10-K/A · filed 2013-11-22 | $1.95M 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $492.02K 10-Q · filed 2012-11-14 | $555.03K derived: sum of 2 quarters · filed 2012-11-14 | $634.50K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2011-06-30 | $63.01K 10-Q · filed 2012-08-13 | $142.47K 10-Q · filed 2012-08-13 | ||||||||||||||||
| 2011-03-31 | $79.46K 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2010-12-31 | $584.30K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |